CD8A and cancer: Blocking checkpoint-inhibitory receptors on exhausted CD8 T cells, including PD-1 and CTLA-4, enhances the proliferation and function of some exhausted T cells, leading to a reduction in viral load or suppression of cancer load [60,62].